Search
Skip to Search Results
Filter
Subject / Keyword
- 2Type 2 diabetes mellitus
- 1Acute coronary syndrome
- 1Antidiabetic agents
- 1Binding affinity
- 1Bradford Hill considerations
- 1Cancer
Author / Creator / Contributor
Year
Collections
Languages
Item type
Supervisors
- 1Johnson, Jeff (Department of Public Health Sciences, University of Alberta)
- 1Seubert, John (Pharmacy and Pharmaceutical Sciences)
- 1Simpson, Scot (Pharmacy and Pharmaceutical Sciences)
- 1Veugelers, Paul (Department of Public Health Sciences, University of Alberta)
- 1Yasui, Yutaka (Department of Public Health Sciences, University of Alberta)
-
Fall 2009
There is substantial evidence of the elevated risk of cancer among individuals with type 2 diabetes. Very little is known, however, about the role that antidiabetic therapies play in this relationship. The objective of this program of research was to examine whether there is a therapeutic risk...
-
Building Evidence to Assess a Drug Safety Signal: the Association between Sulfonylureas and Adverse Cardiovascular Events
DownloadFall 2015
All drugs have the potential to cause adverse events that can result in hospitalization or death. In order to protect the public health, it is critical to employ methods to detect and assess adverse drug events in a timely manner. One of the most controversial and long standing drug safety issue...
1 - 2 of 2